Program

116
16
6
4
3

Journal Year Published

9
10
12
5
13
10
12
12
12
7
5
15
10
1

Author

133
201
181
149
139
133
125
123
108
105
95
82
78
63
62
54
50
46
43
43

Category

56
45
28
20
13
6
5
4
3
1

Keyword

63
35
27
25
22
17
17
17
14
11
10
10
9
9
9
9
8
7
7
7

Journal

13
9
8
7
5
5
4
4
3
3
3
3
3
2
2
2
2
2
2
2

NCATS Publications

A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.


Cubitt B, Ortiz-Riano E, Cheng BY, Kim YJ, Yeh CD, Chen C, Southall N, Zheng W, Martinez-Sobrido L, de la Torre JC


Antiviral Res. , (173), 104667, 2020.

Article Pubmed

Sample image from publication page

The use or generation of biomedical data and existing medicines to discover and establish new treatments for patients with rare diseases - recommendations of the IRDiRC Data Mining and Repurposing Task Force.


Southall N, Natarajan M, Lau LPL, Jonker AH, Deprez B, Guilliams T, Hunter L, Rademaker CM, Hivert V, Ardigò D, IRDiRC Data Mining and Repurposing Task Force


Orphanet J Rare Dis , (14), 225, 2019.

Article Pubmed

Identification, design and synthesis of novel pyrazolopyridine influenza virus nonstructural protein 1 antagonists.


Patnaik S, Basu D, Southall N, Dehdashti S, Wan K, Zheng W, Ferrer-Alegre M, Taylor M, Engel DA, Marugan JJ


Bioorg. Med. Chem. Lett. , (29), 1113-1119, 2019.

Article Pubmed

Sample image from publication page

Sunitinib promotes myogenic regeneration and mitigates disease progression in the mdx mouse model of Duchenne muscular dystrophy.


Fontelonga TM, Jordan B, Nunes AM, Barraza-Flores P, Bolden N, Wuebbles RD, Griner LM, Hu X, Ferrer-Alegre M, Marugan J, Southall N, Burkin DJ


Hum. Mol. Genet. , (28), 2120-2132, 2019.

Article Pubmed

Sample image from publication page

A randomized, proof-of-concept clinical trial on repurposing chlorcyclizine for the treatment of chronic hepatitis C.


Koh C, Dubey P, Han MAT, Walter PJ, Garraffo HM, Surana P, Southall N, Borochov N, Uprichard SL, Cotler SJ, Etzion O, Heller T, Dahari H, Liang TJ


Antiviral Res. , (163), 149-155, 2019.

Article Pubmed

Sample image from publication page

A large scale high throughput screen identifies chemical inhibitors of phosphatidylinositol 4-kinase type II alpha.


Sengupta N, Jović M, Barnaeva E, Kim D, Hu X, Southall N, Dejmek M, Mejdrova I, Nencka R, Baumlova A, Chalupska D, Boura E, Ferrer-Alegre M, Marugan J, Balla T


J. Lipid Res. , 2019.

Article Pubmed

Sample image from publication page